Robert Paul Harris, Director at Aralez Pharmaceuticals Inc. (ARLZ), sold 150,000 shares at $6.04 ($873K) on 2016-09-15, disclosed to the SEC on 2016-09-19.
Open-market sale of $873k ARLZ by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.60 | 75,000 | $420K | 48.1% |
| 2 | $6.04 | 75,000 | $453K | 51.9% |
| Total | $5.82 avg | 150,000 | $873K | 100% |
| Filing → |